In this case, LLPS may be a revolutionary target of precision medicine for heart failure, as Xie et al. found that the inhibition of the LLPS of RUNX family transcription factor 2 (Runx2) can reverse pathological cardiac remodeling due to heart failure [18]. Here, HNF1B is linked to heart failure.